Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto.

The approval is only for the 2.5mg tablet. Xarelto is also available in 10mg, 15mg, and 20mg tablets, as well as an oral suspension (1mg/mL), to treat various conditions.

The results showed that patients taking diltiazem had a 20% higher risk of being hospitalized or dying due to serious ...

The following is a summary of “Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: ...

STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty pharmaceuticals, continued its profitable growth journey in 2024. STADA again outperformed the ...

Following approval from the Republic of the Philippines Securities and Exchange Commission, the company's step-down ...

Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...

As per provisional closing, the barometer index, the S&P BSE Sensex, declined 217.41 points or 0.29% to 74,115.17. The Nifty 50 index lost 92.20 points or 0.41%, to 22,460.30.

The pharmaceutical company Lupin has introduced Rivaroxaban tablets (USP, 2.5 mg) in the U.S. following the final approval of its Abbreviated New Drug Application by the US FDA. This drug is ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.